Insider Transactions in Q4 2023 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 30
2023
|
Teresa L. Young |
SELL
Open market or private sale
|
Direct |
2,907
-25.59%
|
$2,907
$1.35 P/Share
|
Oct 30
2023
|
Eric D. Shaff CEO and President |
SELL
Open market or private sale
|
Direct |
8,552
-6.89%
|
$8,552
$1.35 P/Share
|
Oct 30
2023
|
Paula Cloghessy Officer |
SELL
Open market or private sale
|
Direct |
2,904
-5.98%
|
$2,904
$1.35 P/Share
|
Oct 30
2023
|
Matthew R. Henn |
SELL
Open market or private sale
|
Direct |
3,886
-6.45%
|
$3,886
$1.35 P/Share
|
Oct 30
2023
|
Lisa Von Moltke |
SELL
Open market or private sale
|
Direct |
4,232
-30.79%
|
$4,232
$1.35 P/Share
|
Oct 30
2023
|
David S. Ege |
SELL
Open market or private sale
|
Direct |
4,066
-5.72%
|
$4,066
$1.35 P/Share
|
Oct 30
2023
|
Thomas Des Rosier Chief Legal Officer and EVP |
SELL
Open market or private sale
|
Direct |
4,156
-3.52%
|
$4,156
$1.35 P/Share
|
Oct 30
2023
|
David Arkowitz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,066
-2.26%
|
$4,066
$1.35 P/Share
|
Oct 27
2023
|
Teresa L. Young |
BUY
Exercise of conversion of derivative security
|
Direct |
11,361
+50.0%
|
-
|
Oct 27
2023
|
Eric D. Shaff CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
27,838
+18.31%
|
-
|
Oct 27
2023
|
Paula Cloghessy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,418
+16.24%
|
-
|
Oct 27
2023
|
Matthew R. Henn |
BUY
Exercise of conversion of derivative security
|
Direct |
12,623
+17.32%
|
-
|
Oct 27
2023
|
Lisa Von Moltke |
BUY
Exercise of conversion of derivative security
|
Direct |
13,745
+50.0%
|
-
|
Oct 27
2023
|
David S. Ege |
BUY
Exercise of conversion of derivative security
|
Direct |
11,361
+13.78%
|
-
|
Oct 27
2023
|
Thomas Des Rosier Chief Legal Officer and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
13,501
+10.26%
|
-
|
Oct 27
2023
|
David Arkowitz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,209
+6.84%
|
-
|